Emerging Roles of Orphan Nuclear Receptors in Cancer
Authors:
- 10 February 2014
- journal article
- review article
- Published by Annual Reviews in Annual Review of Physiology
- Vol. 76 (1) , 177-195
Abstract
A growing body of evidence suggests that a subset of orphan nuclear receptors are amplified and prognostic for some human cancers. However, the specific roles of these orphan nuclear receptors in tumor progression and their utility as drug targets are not fully understood. In this review, we summarize recent progress in elucidating the direct and indirect involvement of orphan nuclear receptors in cancer as well as their therapeutic potential in a variety of human cancers. Furthermore, we contrast the role of orphan nuclear receptors in cancer with the known roles of estrogen receptor and androgen receptor in hormone-dependent cancers.Keywords
This publication has 119 references indexed in Scilit:
- EZH2 Generates a Methyl Degron that Is Recognized by the DCAF1/DDB1/CUL4 E3 Ubiquitin Ligase ComplexMolecular Cell, 2012
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapyTrends in Pharmacological Sciences, 2012
- Adrenocortical stem and progenitor cells: Implications for adrenocortical carcinomaMolecular and Cellular Endocrinology, 2012
- The Metabolic Regulator ERRα, a Downstream Target of HER2/IGF-1R, as a Therapeutic Target in Breast CancerCancer Cell, 2011
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligandNature, 2011
- p53 post-translational modification: deregulated in tumorigenesisTrends in Molecular Medicine, 2010
- ERRα: a metabolic function for the oldest orphanTrends in Endocrinology & Metabolism, 2008
- A Short Nur77-Derived Peptide Converts Bcl-2 from a Protector to a KillerCancer Cell, 2008
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997